How Sky-High Short Interest Could Impact These Biotechs

Short interest has swelled on Heron Therapeutics Inc (NASDAQ:HRTX), The Medicines Company (NASDAQ:MDCO), and BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

Sep 30, 2015 at 3:18 PM
facebook X logo linkedin


Biotechs have been garnering attention of late, with a number of drugmakers taking it on the chin -- and, as a result, weighing on the Nasdaq. While the sector is on the mend today amid a broad-market surge, Schaeffer's Quantitative Analyst Chris Prybal recently noticed that short interest on a handful of biotechs was at levels not seen in years, among stocks trading above $5. Three names he flagged -- and which will become the focus of our discussion -- are Heron Therapeutics Inc (NASDAQ:HRTX), The Medicines Company (NASDAQ:MDCO), and BioDelivery Sciences International, Inc. (NASDAQ:BDSI).

Over 5 million HRTX shares are sold short right now -- an amount that hasn't been exceeded in at least a decade. During the latest reporting period, short interest popped almost 12%, and now accounts for 14.2% of the equity's float -- representing roughly four days of pent-up buying power, at average volumes.

This, despite HRTX's phenomenal track record on the charts. Today, the stock has surged 4.5% to hover near $22.30, bringing its year-to-date advance near 122%. Of course, not everything's been sunshine and lollipops for the equity, which pulled back sharply after hitting a five-year high of $42.25 one week ago on positive drug data. However, if HRTX can regain its longer-term footing going forward, a capitulation among shorts could result in tailwinds.

Moving along, 23.2% of MDCO's float is sold short -- the highest amount in at least a decade. At the stock's average trading rate, it would take over six sessions to cover these positions -- suggesting there's plenty of cash on the sidelines.

That pent-up buying demand could soon be unleashed, assuming MDCO continues to run higher. The shares have tacked on roughly 37% in 2015 to trade at $37.81, and earlier this month topped out at a record $43.79. They've since pulled back to their 40-day moving average, and a bounce from this trendline could force short sellers to throw in the towel.

Finally, BDSI short interest is at decade-high levels. By the numbers, 12.8 million shares are sold short -- or 27.4% of the stock's total float. At the equity's typical trading pace, it would take more than two weeks to buy back these shorted shares.

Unlike the other equities we've mentioned, though, this bearish attention is warranted. BDSI has lost over half its value in 2015 to trade at $5.61. Continued short selling -- or a capitulation among analysts, all of whom consider the shares a "strong buy" -- could send the stock even lower.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI